Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24


Adherence to antiretroviral therapy for HIV/AIDS in Latin America and the Caribbean: Systematic review and meta-analysis.

Costa JM, Torres TS, Coelho LE, Luz PM.

J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25066. Review.


Associations Between At-Risk Alcohol Use, Substance Use, and Smoking with Lipohypertrophy and Lipoatrophy Among Patients Living with HIV.

Noorhasan M, Drozd DR, Grunfeld C, Merrill JO, Burkholder GA, Mugavero MJ, Willig JH, Willig AL, Cropsey KL, Mayer KH, Blashill A, Mimiaga M, McCaul ME, Hutton H, Chander G, Mathews WC, Napravnik S, Eron JJ, Christopoulos K, Fredericksen RJ, Nance RM, Delaney JC, Crane PK, Saag MS, Kitahata MM, Crane HM.

AIDS Res Hum Retroviruses. 2017 Feb 16. doi: 10.1089/AID.2015.0357. [Epub ahead of print]


People living with HIV on ART have accurate perception of lipodystrophy signs: a cross-sectional study.

Alencastro PR, Barcellos NT, Wolff FH, Ikeda ML, Schuelter-Trevisol F, Brandão AB, Fuchs SC.

BMC Res Notes. 2017 Jan 13;10(1):40. doi: 10.1186/s13104-017-2377-3.


HIV seropositivity and sexuality: cessation of sexual relations among men and women living with HIV in five countries.

Bernier A, Lefèvre M, Henry E, Verdes L, Acosta ME, Benmoussa A, Mukumbi H, Cissé M, Otis J, Préau M.

AIDS Care. 2016;28 Suppl 1:26-31. doi: 10.1080/09540121.2016.1146208. Epub 2016 Feb 28.


Pharmacogenetics as a tool to tailor antiretroviral therapy: A review.

Aceti A, Gianserra L, Lambiase L, Pennica A, Teti E.

World J Virol. 2015 Aug 12;4(3):198-208. doi: 10.5501/wjv.v4.i3.198. Review.


Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disorders.

Verolet CM, Delhumeau-Cartier C, Sartori M, Toma S, Zawadynski S, Becker M, Bernasconi E, Trellu LT, Calmy A; LIPO Group Metabolism.

AIDS Res Ther. 2015 Jun 20;12:21. doi: 10.1186/s12981-015-0061-z. eCollection 2015.


HIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settings.

Finkelstein JL, Gala P, Rochford R, Glesby MJ, Mehta S.

J Int AIDS Soc. 2015 Jan 15;18:19033. doi: 10.7448/IAS.18.1.19033. eCollection 2015. Review.


Adolescents with HIV and facial lipoatrophy: response to facial stimulation.

Gabana-Silveira JC, Mangilli LD, Sassi FC, Braga AF, Andrade CR.

Clinics (Sao Paulo). 2014 Aug;69(8):574-8.


HIV-associated lipodystrophy: a review from a Brazilian perspective.

Alves MD, Brites C, Sprinz E.

Ther Clin Risk Manag. 2014 Jul 17;10:559-66. doi: 10.2147/TCRM.S35075. eCollection 2014. Review.


Subdermal fat grafting for Parry-Romberg syndrome.

Balaji SM.

Ann Maxillofac Surg. 2014 Jan;4(1):55-9. doi: 10.4103/2231-0746.133081.


Assessing appearance-related disturbances in HIV-infected men who have sex with men (MSM): psychometrics of the body change and distress questionnaire-short form (ABCD-SF).

Blashill AJ, Wilson JM, Baker JS, Mayer KH, Safren SA.

AIDS Behav. 2014 Jun;18(6):1075-84. doi: 10.1007/s10461-013-0620-z.


The association of self-perception of body fat changes and quality of life in the Women's Interagency HIV Study.

Plankey M, Bacchetti P, Jin C, Dass-Brailsford P, Gustafson D, Cohen MH, Karim R, Yin M, Tien PC.

AIDS Care. 2013;25(12):1544-50. doi: 10.1080/09540121.2013.793265. Epub 2013 May 8.


Depression longitudinally mediates the association of appearance concerns to ART non-adherence in HIV-infected individuals with a history of injection drug use.

Blashill AJ, Gordon JR, Safren SA.

J Behav Med. 2014 Feb;37(1):166-72. doi: 10.1007/s10865-012-9476-3. Epub 2012 Nov 22.


Incidence of treatment-limiting toxicity with stavudine-based antiretroviral therapy in Cambodia: a retrospective cohort study.

Phan V, Thai S, Choun K, Lynen L, van Griensven J.

PLoS One. 2012;7(1):e30647. doi: 10.1371/journal.pone.0030647. Epub 2012 Jan 27.


Management of the metabolic effects of HIV and HIV drugs.

Brown TT, Glesby MJ.

Nat Rev Endocrinol. 2011 Sep 20;8(1):11-21. doi: 10.1038/nrendo.2011.151. Review.


Self-reported body changes and associated factors in persons living with HIV.

Giudici KV, Duran AC, Jaime PC.

J Health Popul Nutr. 2010 Dec;28(6):560-6.


Self-perception of body fat changes and HAART adherence in the Women's Interagency HIV Study.

Plankey M, Bacchetti P, Jin C, Grimes B, Hyman C, Cohen M, Howard AA, Tien PC.

AIDS Behav. 2009 Feb;13(1):53-9. doi: 10.1007/s10461-008-9444-7. Epub 2008 Aug 8.


Approach to the human immunodeficiency virus-infected patient with lipodystrophy.

Brown TT.

J Clin Endocrinol Metab. 2008 Aug;93(8):2937-45. doi: 10.1210/jc.2008-1019. Review.


Severity of lipodystrophy is associated with decreased health-related quality of life.

Guaraldi G, Murri R, Orlando G, Giovanardi C, Squillace N, Vandelli M, Beghetto B, Nardini G, De Paola M, Esposito R, Wu AW.

AIDS Patient Care STDS. 2008 Jul;22(7):577-85. doi: 10.1089/apc.2007.0173.


Impact of lipoatrophy on quality of life in HIV patients receiving anti-retroviral therapy.

Rajagopalan R, Laitinen D, Dietz B.

AIDS Care. 2008 Nov;20(10):1197-201. doi: 10.1080/09540120801926993.

Supplemental Content

Support Center